NWRN.SW
NWRN.SW
IT0004147952
NEWRON PHARMA N
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 19.126.000 51.390.000
62.8%
Cost of Revenue -- --
--
Gross Profit -- --
--
23.823.000 25.217.000
5.5%
Operating Income -4.697.000 26.173.000
117.9%
Pretax Income -12.354.000 21.394.000
157.7%
Net Income Common Stockholders -13.239.000 15.843.000
183.6%
-- --
--
-- --
--
ende